The application of autologous endothelial progenitor cells (EPC) is a promising approach in cardiovascular regeneration, but the availability of cells in appropriate numbers is the limiting factor. Allogeneic EPC would be an alternative, and we therefore analysed the immunogenicity of EPC-derived endothelial cells (EC) to evaluate their potential usefulness.
Introduction
Recently, endothelial progenitor cells (EPC) were described as circulating cells that promote neovascularization at sites of ischaemia, hypoxia, injury, or tumour formation. The first-reported progenitor cell type, the colony-forming unit -Hill cells, 1,2 originate from nonadherent peripheral blood mononuclear cell (PBMC) cultures on fibronectin-coated dishes. Although these colony-forming cells display several typical markers of the endothelial lineage, they are not able to form vascular structures in vivo. This latter characteristic also applies to circulating angiogenic cells, referred to as early-outgrowth cells, 3, 4 which are in fact descendants of the monocyte-macrophage subset and play a role in the vascular regulation of homeostasis and initiation of neo-angiogenesis during wound healing, tissue ischaemia, and tissue remodelling. The third EPC type, designated as late-outgrowth cells or endothelial colonyforming cells (ECFC), exhibits the capacity to express all typical properties of endothelial cells and in addition can contribute to de novo blood vessel formation in vivo. 5 This rare EPC subtype which displays a high proliferative capacity could be detected in low quantities within adult peripheral blood as well as in umbilical cord blood. 6, 7 ECFC show all typical endothelial markers, but are negative for CD45, CD14, and CD115, and are not able to ingest bacteria. Furthermore, in animal experiments, these cells spontaneously formed blood vessels or became a part of the systemic circulation system. 8, 9 Therefore, an EPC can be more strictly defined as a circulating cell displaying the ability to produce endothelial progeny with competence to develop endothelial structures in vitro as well as in vivo and to contribute to the endothelial lining of injured or de novo emergent vascular structures. Several clinical implications were suggested for EPC, based on their vascular protective functions, including their use as cellular biomarkers for endothelial damage, and their mobilization by pharmacological modulation to enhance the body's repair mechanisms. Furthermore, bioengineering applications for EPC have been developed especially in the cardiovascular field. 10 There are several clinical trials investigating the restoration of blood flow by transplantation of autologous progenitor cells in ischaemic hearts or limbs, as well as in myocardial infarction or chronic ischaemic heart disease. 10 Moreover, EPC have been used for the endothelialization of stent and graft material in vitro, 11, 12 in animal models 13 and even in preliminary clinical studies. 14 EPC seem to promote the patency of small-diameter blood vessels, attenuate de-endothelialization of injured arteries, 15 and reduce neointima formation. 16 Very little is known so far concerning the immunogenic potential of EC differentiated from EPC. Most studies have focused on the application of freshly isolated or short-term cultured EPC either in animal models with immunodeficient recipients 17, 18 or based on autologous cells, though the clinical usefulness of these approaches is limited by the low yield of the cells and the time to culture them. 13, 15 However, the use of non-autologous cell material has not been considered because of the theoretical danger of allorejection.
The main purpose of the present study was therefore to examine the immunogenicity of EPC-derived endothelial cells in terms of (i) the surface antigen expression that mediates immune allorecognition, (ii) their susceptibility to humoral and cellular attacks, and (iii) their immunogenicity in vivo as constituents of grafted vessels. Furthermore, we demonstrated the incorporation of EPC-derived EC into newly formed blood vessels in vivo, confirming their identification as the late-outgrowth cell type. The discovery that EPC-derived EC have low immunogenic features suggests the potential use of nonautologous donor cells for therapeutic interventions in the field of cardiovascular repair.
Methods

Animals
All animal studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and under the approval of local authority (Landesamt für Gesundheit und Soziales Berlin; G0023/06). Male Wistar-Kyoto (WKY; haplotype RT1A l ) and BDIX (haplotype RT1A dv1 ) rats were purchased from Charles River (Sulzfeld, Germany) and Wistar-Furth rats (haplotype RT1A u ) were purchased from Harlan-Winkelmann (Borchen, Germany).
Cell culture
Primary rat aortic endothelial cells (EC) were isolated from Wistar-Kyoto, BDIX and Wistar-Furth rats as described elsewhere. 19 EC were cultured in endothelial basal medium (EBM) with 10% FCS (both PAA), 50 mg/mL gentamicin, 2 mM L-glutamine, and 6 mg/mL endothelial cell growth supplement in 0.2% gelatine-coated dishes (all Sigma). EPC were isolated from the blood of WKY rats by density gradient centrifugation with Pancoll rat (PAN-Biotech), and by performing a CD45-depletion using a mouse anti-rat CD45 monoclonal antibody (AbD Serotec) and Pan-mouse-IgG Dynabeads (Dynal Biotech). The CD45(2) fraction was cultured in endothelial differentiation medium [EBM supplemented with 5% FCS, 50 mg/mL gentamicin, 10 ng/mL rat VEGF (Biosource), 1 ng/mL bovine bFGF, 10 ng/mL murine IGF-1 (both R&D Systems), 10 ng/mL murine EGF, and 1 mg/mL hydrocortisone] in 20 mg/mL fibronectincoated dishes (all Sigma). Non-adherent cells were removed by medium change every 4 days. Outgrowing cell clusters appeared after 15 -22 days of culture, and were picked by trypsinization inside cloning rings. PECAM-1(+) cells were selected with MACS separation using a PECAM-1 mouse anti-rat monoclonal antibody (BD Pharmingen TM ) and rat anti-mouse IgG1 MicroBeads (Miltenyi Biotec). The PECAM-1(+) fraction was further cultured up to passage 25. For stimulation experiments, cells were treated with 10 ng/mL rat interferon-g (HbT) as indicated.
Flow cytometry
Surface expression patterns and phosphorylation status were analysed by flow cytometry. Labelling of surface markers was performed using mouse anti-rat monoclonal antibodies to MHC I (RT1.A), MHC II (RT1.B), PECAM-1, ICAM-1, VCAM-1, or an isotype control IgG1 k (all BD Pharmingen TM ); or a rabbit anti-rat polyclonal antibody to VE-Cadherin (Alexis Biochemicals) or the appropriate isotype control antibody. A donkey anti-mouse IgG-PE polyclonal antibody (Dianova) or a goat antirabbit IgG-PE polyclonal antibody (Southern Biotechnology) was used as secondary antibodies. Phosphorylation of STAT1 was determined using the BD TM Phosflow Kit including the anti-phospho-STAT1-PE antibody (BD Pharmingen).
For details of low-density lipoprotein (LDL) uptake assays, intracellular von Willebrand factor (vWF) staining, and the tube-forming assay, please refer to the Supplementary material.
Histological evaluation
Cryostat sections (5 mm) were washed in PBS/0.3% Triton-X and PBS. Tissue specimens were blocked (1 h, RT) with PBS/5% goat serum (Sigma). Primary antibodies such as rabbit anti-rat VE-cadherin (Axxora), rabbit anti-vWF antibody, or an appropriate isotype control antibody (both Sigma), respectively, were incubated for 20 h at 48C. After washing with PBS/5% goat serum, sections were incubated with the secondary antibody goat anti-rabbit ALEXA488 (Axxora) (1.5 h, RT), counterstained with DAPI (Invitrogen), and mounted with mounting medium Confo30 (Micro-Tech-Lab).
Immunohistochemistry was performed as described elsewhere 20 using primary antibodies against PECAM-1, CD68, TCR, and MHC II or with a non-immune IgG isotype-identical control antibody (all BD Pharmingen).
Vessel formation in vivo
The formation of vascular structures in vivo was analysed in a rat skin transplantation model with WKY rats. Skin grafts (1 cm in diameter) from the tail of euthanized 10-week-old WKY rats were harvested. Recipient rats were anesthetized intramuscularly using ketamine hydrochloride (Ketavet w , WDT, 80 -100 mg/kg) and xylazine hydrochloride (Rompun w , Bayer, 0.8-1.6 mg/kg). The graft bed was prepared by removing approximately 1 cm 2 of full-thickness skin on the dorsal side of the rat. Skin grafts were then moulded into the graft bed. EPC-derived EC were harvested and Dil-labelled according to the manufacturer's instructions (Invitrogen), and 1 × 10 6 cells were injected at four sites on the graft rim. After successful engraftment, animals were euthanized and the grafts were harvested for histological analysis on days 8 -10. Grafts were embedded into Tissue freezing medium (Leica), snap-frozen in liquid nitrogen, and stored at 2708C.
Decellularization of native rat arteries and seeding with EPC-derived EC
Aortic grafts were decellularized by a method similar to those described by Kasimir et al. 21 Descending aortic tissues were harvested from euthanized male BDIX rats after ligation of all branches with 8-0 nylon suture (S&T AG). After flushing with 0.1% heparin solution (Braun), the aortic grafts were washed in PBS and incubated for 2 h in 1 M NaCl solution at 378C, followed by 48 h incubation with 0.25% sodium desoxycholate and 0.25% Triton-X (both Sigma) at 378C with continuous shaking. After additional PBS washing steps for the next 3 days, the aortic tissue was equilibrated with EPC medium for 2 h at 378C/5% CO 2 . EPCderived EC were trypsinized, Dil-labelled (Invitrogen), and seeded into the lumen of the aortic vessels with a density of 1 × 10 7 /mL for 6 -8 h. After rotation, grafts were incubated for a further 16 h, and then gently flushed with medium and cultured under static conditions for 7 days until grafting, with medium exchange every 2 days.
Aortic transplantation
Arteries were transplanted using a well-established surgical procedure. Male 10 -12-week-old BDIX (RT1A dv1 ) or WKY (RT1A l ) recipient rats were anesthetized intramuscularly with ketamine hydrochloride (Ketavet w , WDT, 80 -100 mg/kg) and xylazine hydrochloride (Rompun w , Bayer, 0.8-1.6 mg/kg). After laparotomy midline, the abdominal descending aorta was separated from surrounding tissue, dissected from the inferior vena cava, closed proximally and distally with microvascular clamps (FST GmbH) and then severed between the clamps. Seeded aortic grafts (approximately 12 -14 mm in length and 0.9 mm in diameter) were implanted interpositionally below the renal arteries and above the iliac bifurcation into the descending aorta by performing end-to-end anastomosis of the graft and the recipient artery with 8-0 nylon suture (S&T AG). Once distal anastomosis was completed, blood flow was re-established by de-clamping. Anastomosis time varied between 30 and 40 min. Buprenorphine hydrochloride (Temgesic w , Essex Pharma, 0.1 mg/kg) was applied for analgesia for 3 days following the procedure. Fourteen days post-operation rats were sacrificed and the grafted artery was harvested, flushed with saline and fixed for 1 h in 2% paraformaldehyde solution (Roth). Tissue was incubated for 2 h in 30% sucrose solution (Sigma) and embedded in tissue-freezing medium, frozen in liquid nitrogen and stored at 2708C until processing.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted using the Absolutely RNA RT -PCR Miniprep Kit (Stratagene), reverse transcribed into cDNA, and subjected to quantitative real-time PCR utilizing the GeneAmp w 5700 Sequence Detection System (Applied Biosystems). Analyses were performed using the SYBR w Green PCR Kit (Applied Biosystems) and rat-specific primers designed for interferon-g receptor chain 1 (IFNgR1), interferon-g receptor chain 2 (IFNgR2), and class II transactivator (CIITA) (all synthesized by Metabion); for sequences, please refer to the Supplementary material. The specificity of the desired gene products was examined by melting-curve analysis. The expression of the housekeeping gene b-actin was used to normalize the amount of transcript in the samples. Relative expression levels of the target gene mRNA were calculated by means of the formula (2 −DCt ).
Alloantibody/complement assay
Alloantibody/complement-mediated lysis of mature and EPC-derived EC was determined as described previously. 22 Relative lysis rates were calculated as the quotient of (specific lysis 7-AAD(+) cells with allospecific serum )/ (spontaneous lysis 7-AAD(+) cells without serum ).
One-way mixed lymphocyte reaction
Mature EC, EPC-derived EC, and mononuclear cells (MNC) were used as stimulator cells. Allogeneic (WKY), syngeneic (BDIX) mature EC, and allogeneic EPC-derived EC were seeded into 96-well plates, pre-treated with 10 ng/mL IFNg (48 h) or left untreated. WKY and BDIX MNC were freshly isolated from lymph nodes and seeded into 96-well plates. All stimulator cells were irradiated at 30 Gray. Responder CD4(+) T cells were isolated from BDIX lymph nodes by MACS separation using rat CD4-MicroBeads (Miltenyi Biotec), labelled with CFDA-SE (2.5 mM, 4 min; Invitrogen), and plated at the indicated responder:stimulator ratio (adherent cells 10:1, MNC 1:1). Cells were cultured in RPMI 1640 with 10% FCS, 100 U/mL penicillin, 100 mg/mL streptomycin (both Life Technologies), 2 mM L-glutamine, 5 mM HEPES, 50 mM b-mercaptoethanol (all Sigma), and 2% autologous serum for up to 5 days at 378C. To assess autoproliferation, CD4(+) cells were cultured in medium alone. Samples from days 3 and 5 were labelled with a mouse anti-rat CD4-PE monoclonal antibody (BD Pharmingen) and analysed by flow cytometry with gating on the CD4(+)/CFDA-SE(+) lymphocyte population.
The stimulation index was calculated as the quotient of (sample proliferation)/(auto-proliferation of CD4(+) cells without stimulation). For a description of the cytotoxicity assay, please refer to the Supplementary material.
Statistical analysis
Data are presented as mean values per group + SEM, and were statistically analysed using the non-parametric Mann-Whitney U test for unpaired data. Differences between groups were considered significant at *P , 0.05 and **P , 0.01.
Results
EPC-derived EC are similar to mature EC
Phenotypical characteristics of EC derived from EPC were analysed and compared with the phenotype of mature primary EC of aortic origin. The expression pattern of several endothelial surface markers was determined by flow cytometry ( Figure 1A) . EPC-derived EC showed low constitutive levels of major histocompatibility complex class I (MHC I; RT1.A), which were significantly diminished by 20-fold compared with the high expression levels on mature EC (P , 0.01). MHC class II (MHC II; RT1.B) was not expressed constitutively on either cell type. Platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) were detectable in comparably high densities on both EPC-derived EC and mature EC. Vascular cell adhesion molecule-1 (VCAM-1), which is a marker for activated endothelium, was almost undetectable in EPC-derived EC in contrast to its distinct expression on mature EC. Vascular/endothelial (VE) cadherin, which is important for maintenance of vessel barrier permeability, was also expressed in equal intensities on both cell types. EPC-derived EC were CD45(2), CD11a(2), and CD11b(2) (data not shown). Both cell types showed similar characteristics with regard to morphology, cytoplasmic expression of von Willebrand factor (vWF) protein, uptake of Dil-labelled acetylated LDL (Dil-Ac-LDL), and formation of vessellike structures on extracellular matrix (see Supplementary material online, Figure S1 ). To verify that EC were derived from EPC, we performed in vivo studies to confirm the involvement of the Dil-labelled EPC-derived EC in newly formed vascular structures following skin transplantation. After syngeneic skin grafting, new vessel structures developed 8-10 days post-transplantation. By immunofluorescence costaining of the Dil-labelled EPC-derived EC with endothelial markers such as vWF or VE-cadherin, we demonstrated the close spatial proximity and partial integration of EPC-derived EC into vascular structures ( Figure 1B) confirming the presence of this typical attribute of EPC.
Immune privilege of endothelial progenitors
Responses to the pro-inflammatory cytokine interferon-g
The effect of inflammatory stimuli is of great interest in transplantation and vascular diseases; hence, we investigated the responsiveness of the two different cell types to the pro-inflammatory cytokines tumour necrosis factor-a (TNFa) and interferon-g (IFNg). We stimulated mature EC and EPC-derived EC with 10 ng/mL of either cytokine for 24 h and analysed the MHC surface expression patterns with flow cytometry. TNFa did not show any impact on the MHC expression (data not shown), but IFNg induced MHC I and II on the analysed cell types. However, as with resting cells, we observed more than a 30-fold reduction of MHC I expression on IFNgstimulated EPC-derived EC as well (Figure 2A) . Remarkably, the extent of MHC I upregulation was comparable in mature EC (fivefold) and EPC-derived EC (three-fold). With regard to MHC II surface expression after IFNg treatment, we found a substantial induction in mature EC, but to a significantly lesser extent for EPCderived EC ( Figure 2B) . The differential responses to IFNg stimulation in terms of MHC expression remained stable throughout the culture, regardless of the passage number.
To understand these different responses to IFNg, we investigated the respective signalling pathways. First, the IFNg receptor mRNA profile was assessed by qRT-PCR. The ligand-binding IFNg receptor chain 1 (IFNgR1) was expressed at comparable levels in both cell types.
However, the signal transducing receptor chain 2 (IFNgR2) was significantly reduced in EPC-derived EC ( Figure 3A) . Analysis of the IFNg receptor expression at the protein level was not successful due to the lack of specificity of the available antibodies. After stimulation with 10 ng/mL IFNg for 5 min, a complete and strong phosphorylation of the signal transducer and activator of transcription 1 (STAT1) was detected in mature EC, whereas in EPC-derived EC this phosphorylation was incomplete and less robust ( Figure 3B ). As the discrepancies in IFNg responses were most prominent with regard to the MHC II expression, we investigated the IFNg-dependent induction of the CIITA by qRT-PCR. Following exposure to 10 ng/mL IFNg for 6 h, induction of CIITA mRNA was significantly increased (.10-fold) in mature EC compared with EPC-derived EC ( Figure 3C) ; CIITA expression of unstimulated cells stayed below the detection limit.
Immunogenicity and protection against humoral and cellular alloresponse in vitro
Cellular allorecognition of EC is mainly related to their expression of MHC molecules. The inducible expression of MHC II under inflammatory conditions is pivotal to triggering responder CD4(+) T cells. The recognition of allogeneic EC by primed recipient cytotoxic CD8(+) T lymphocytes (CTL) is primarily driven by donor MHC I on these allogeneic cells. In order to determine the allostimulatory capacity on responder CD4(+) T cells, CFDA-SE-based proliferation analyses were performed. Cells were pre-treated with 10 ng/mL IFNg for 48 h to induce MHC II expression, or left untreated and co-cultured with allogeneic CD4(+) responder cells. On day 3, a distinct proliferation of responder cells (10.5 + 3.2%) was already detectable in co-cultures with IFNg-stimulated allogeneic mature EC. However, the allostimulatory potential of IFNg-treated EPC-derived EC was markedly reduced (3.8 + 2.1%, P , 0.01) ( Figure 4A ). Co-cultures of both unstimulated cell types showed only background proliferation. The stimulation index revealed that proliferation of allogeneic CD4(+) T cells on EPC-derived EC stayed below that of syngeneic mature EC and slightly exceeded (1.5-fold) the level of CD4(+) T cell auto-proliferation. In contrast, allostimulation by allogeneic mature EC induced significantly elevated levels of CD4(+) T cell proliferation (5.4-fold) ( Figure 4B) . The strong phosphorylation of STAT1 (pSTAT1, filled curve) in mature EC was clearly reduced in EPC-derived EC following IFNg exposure. Unstimulated samples remained pSTAT1(2) (dashed curves). pSTAT1 was detected intracellularly by FACS analysis following treatment with 10 ng/mL IFNg for 5 min. One representative experiment is shown (n ¼ 3). (C) Class II transactivator (CIITA) mRNA expression was substantially induced after stimulation with 10 ng/mL IFNg for 6 h in mature EC, whereas in EPC-derived EC induction was diminished. Analysis was performed by qRT -PCR and normalized to the b-actin housekeeping gene expression (n ¼ 6, **P , 0.01).
In contrast to what is found in many animal models, patients frequently express pre-formed humoral and cellular alloresponses, which is sometimes referred to as immune memory. In order to simulate the appropriate conditions, we tested the susceptibility of EPC-derived EC to alloantibody/complement-or CTL-mediated killing. Following contact with allospecific serum diluted 1:5, and complement, 87.1% (median) of the mature EC were positive for 7-AAD, indicating loss of cell integrity. In contrast, cell death was significantly reduced in EPC-derived EC (25.4%, median, P , 0.01) ( Figure 4C ). Susceptibility to serum-induced lysis was dose-dependent. Spontaneous complement-mediated lysis was determined without serum pre-incubation (15.8%, median). Reduced susceptibilities to humoral immune recognition might be caused by decreased alloantibody binding on EPC-derived EC (see Supplementary material online, Figure S2 ).
Responsiveness to CTL-mediated lysis was determined in cytotoxicity assays using pre-activated allospecific CTL, and a significant protection of EPC-derived EC compared with mature EC was observed (see Supplementary material online, Figure S3 ).
Detection of allogeneic EPC-derived EC seeded on vascular grafts in vivo
Experimental data to determine the survival of allogeneic EPC-derived EC grafted as a luminal cell layer in vascular grafts in a rat aortic interposition transplantation model showed their in vivo suitability. Excellent endothelialization of acellular vascular graft matrices was shown after 7 days of static culture in vitro before transplantation with Dil-labelled EPC-derived EC (see Supplementary material online, Figure S4 ). Despite their allogeneic origin, we could detect Dil-labelled EPC-derived EC even 2 weeks after aortic transplantation on the luminal side of the graft ( Figure 5A and B) . Evaluating the aortic transplants seeded with allogeneic EPC-derived EC by immunohistological staining, we found low levels of CD68(+) monocyte and macrophage infiltration, but no T cells, indicating only a mild inflammatory response without signs of ongoing acute rejection or neointima formation. Histological images were similar to acellular grafts endothelialized with syngeneic mature EC and to the autologous adjacent aortic tissue ( Figure 5C ). In contrast, transplants of acellular vascular matrices, seeded with allogeneic mature EC of aortic origin, were characterized by extensive infiltration of CD68(+) monocytes and macrophages as well as T cells, accompanied by a pronounced neointima formation ( Figure 5C ).
Discussion
The use of allogeneic EC would improve their availability in clinical settings compared with autologous EC; however, allogeneic EC are immunogenic. The aim of this study was to determine whether IFNg-pre-treated mature EC displayed a significantly higher stimulation index than IFNg-stimulated EPC-derived EC (n ¼ 5, **P , 0.01). (C ) Following sequential pre-incubation with allospecific serum and complement, lysis rates were assessed by flow-cytometry with 7-AAD staining. Serum-induced cell death was increased in mature EC compared with EPC-derived EC for all serum dilutions. Cell death of EPC-derived EC marginally exceeded levels of spontaneous lysis (n ¼ 6, **P , 0.01; *P , 0.05).
EPC-derived EC might be suitable for an allogeneic application, namely as components of vascular grafts. Therefore, we characterized the in vitro and in vivo immunogenicity of EPC-derived endothelial cells obtained from rat peripheral blood in comparison to fully differentiated rat aortic endothelial cells. As a model system for coronary bypass surgery, we used the rat as a small rodent model of aortic transplantation providing a vessel geometry comparable to that of human arteries. 23 Our data clearly support the usefulness of this cell type due to the astonishingly low alloimmunogenicity and high resistance to pre-formed alloresponses both in vitro and in vivo.
Several reports describe diverse phenotypes of circulating EPC. Most of the studies deal with early cultures of CD14(+)/CD45(+) EPC from blood, displaying several endothelial markers and functions but exhibiting a limited proliferative potency. 24, 25 Another cell type which is described as circulating EPC was found to appear late in culture after 2-4 weeks and is characterized by the absence of CD14 and CD45, while exhibiting an endothelial morphology and a high proliferative capacity. 5, 26 In our approach, we focused on the late-outgrowing EPC, which proliferate strongly. To ensure high efficiency in cell isolation and to prevent contamination by Immune privilege of endothelial progenitors early-outgrowth cells, a CD45 depletion step was added to the density gradient centrifugation. By eliminating the leucocyte subpopulation from the initial culture, we achieved a higher efficiency compared with the procedures normally used by other groups 5, 6, 27 (data not shown). Under angiogenic conditions, late-outgrowing EPC differentiated into mature endothelial cells. These cells did not express CD45, CD11a, or CD11b, illustrating the absence of leucocyte characteristics, including those of monocytes and macrophages. Unfortunately, due to the lack of reagents for the rat system, CD14 could not be measured. EPC-derived EC exhibited a full set of endothelial characteristics, namely the cobblestone-like morphology, surface expression of VE-cadherin, PECAM-1 and ICAM-1, cytoplasmic expression of vWF, uptake of Dil-Ac-LDL, and the formation of branched tubular structures on extracellular matrix in vitro. When applied in a skin transplantation model, these cells preferentially relocated to newly formed vessels at the border zone of the graft and are partially integrated corroborating their EPC origin and their full endothelial function. 9 Neumuller et al. 28 reported early mature EC derived from haematopoietic stem cells to be constitutively MHC I(+) and MHC II(2). EPC-derived EC in our study showed a similar MHC expression pattern. The immunogenicity and antigen-presenting capacity of transplanted allogeneic EC are mainly dependent on the inducible expression of MHC II under pro-inflammatory conditions. 29 Hence,
we compared EPC-derived vs. mature EC with regard to their ability to induce MHC II following IFNg stimulation. Both cell types were able to express MHC II in response to IFNg, but the substantial induction in mature aortic EC was in sharp contrast to the marginal expression on EPC-derived EC. However, MHC I was induced to a comparable extent in both cell types. Phosphorylation of STAT1 in EPC-derived EC was less effective, because of discrepancies in the IFNg receptor chain expression. Consequently CIITA, the key regulator of all MHC II genes and many other genes involved in antigen presentation, was induced incompletely, preventing a full induction of MHC II. 30 Exposure to further pro-inflammatory cytokines known to be important during transplantation such as TNFa 31 did not induce either MHC I or MHC II on the cell types analysed in our model. Activation of CD4(+) T cells via MHC II is crucial for the initiation of the direct pathway of allorecognition. 32 Remarkably, EPC-derived IFNg-stimulated EC featured a very low allostimulatory capacity towards allogeneic CD4(+) T cells in vitro compared with mature EC of the same donor strain. A similar tendency could be revealed in the work of Suarez et al. 33 using human endothelial cells generated from cord blood progenitors. Although stated in the paper as non-significant, the proliferation response of CD4(+) and CD8(+) T cells was reduced both without stimulation and after stimulation with IFNg. Moreover, it was shown by this group that memory cells, in general, display stronger responses compared with naïve cells. The predominance of this naïve cell type in our rat model might explain the potential differences in the observed response levels. Many patients are pre-sensitized to alloantigens, e.g. by pregnancy, transfusions, or crossreactivity. Therefore, we determined the resistance of both EC types to preformed alloresponses. The expression of MHC I on a cellular transplant is able to trigger the activation of recipient CD8(+) T cells promoting graft destruction. 34 In our in vitro cytotoxicity experiments using pre-activated allospecific CTL, we could assess the EPC-derived EC's immune privileged state by a significantly reduced lysis by alloreactive CTL. But due to a persisting MHC I expression, even at low levels, the initiation of a natural killer cell response is unlikely. The humoral immune response via alloantibody in conjunction with complement is also dependent on the expression of MHC I on the cell surface. 35 The low level of MHC I on EPC-derived EC prevented the effective binding of alloantibodies and protected them from complementmediated lysis. In contrast, mature EC exhibited a high susceptibility to humoral allorecognition, resulting in almost complete cell death. Several studies described the high re-endothelialization capacity of transplanted autologous EPC after balloon denudation. 15, 36 Kaushal et al. 13 reported long-term survival using sheep EPC seeded on decellularized grafts in an autologous transplantation setting. To elucidate the immunogenicity of EPC-derived EC in an allogeneic vascular grafting setting, we made use of an allogeneic complete-mismatch aortic transplantation model. EPC-derived EC from rat were able to endothelialize completely acellularized aortic grafts in vitro within a few days. Despite their allogeneic origin, we could detect these cells on the seeded grafts even 2 weeks post-engraftment. The immunohistological analysis revealed only a mild inflammation within the transplant, without neointima formation or involvement of T cells. Contrary to other in vivo models applying human EC derived from cord blood progenitors in SCID-beige mice followed by a reconstitution with allogeneic PBMC, 33 the rat aortic transplantation model allows the analysis of alloresponses directly after engraftment and within an adequate local environment. Using this model system, allogeneic mature aortic EC are strongly attacked by infiltrating immune cells already 2 weeks after transplantation and result in a strong neointima formation of the vascular graft. Hence, EC derived from circulating EPC exhibit an immune privileged state not only in vitro, but also in vivo. Whether this protected state of allogeneic EPC-derived EC is conserved even under systemic pro-inflammatory or infectious challenges is not clear yet and should be further elucidated. Against the background of the low autologous EPC frequencies, especially in elderly patients, this opens up the possibility of using this cell source as an integral part of readily available tissue engineered vascular substitutes in non-autologous applications or repair of ischaemic injured tissues and organs. In summary, our data strongly support the superiority of EPCderived EC over mature EC as a potential allogeneic source. Their low immunogenicity and strong resistance to pre-formed alloresponses make these cells excellent candidates for establishing and storing allogeneic EC for transplantation.
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